Tradestie Institutional Equity Comparison Engine
IPOD vs ABSI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IPOD Overall Edge
IPOD Captures Institutional Edge (3โ1 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to IPOD (IPOD) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABSI counters with relative strength in Options & Structure. Fundamentally, IPOD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABSI at N/M Forward P/E and -9108.3% operating margin (-19.6% YoY). In options structure, IPOD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
IPOD
IPOD N/M vs ABSI N/M Fwd P/E
Growth & Margin Winner
IPOD
Op Margin 0.0% vs -9108.3% ยท YoY +0.0% vs -19.6%
Momentum & Technical Winner
IPOD
1Y +3.8% vs +183.1% ยท 52W Pos 100% vs 51%
Options & Structure Winner
ABSI
UNCLASSIFIED (N/A IV) vs BREAKDOWN (15th %ile IV)
IPOD
US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap
$210.0M
1M Return
+0.97%
1Y Return
+3.84%
Forward P/E
N/M
Unified AI Score
58.0 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
ABSI
NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.47
-11.54% 1D
Market Cap
$1.5B
1M Return
-9.39%
1Y Return
+183.14%
Forward P/E
N/M
Unified AI Score
41.3 / 100
SELL
Tech 30.0
Fund 52.0
Flow 71.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IPOD +3.84%
ABSI +183.14%
Spread: +85.47 pp (ABSI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IPOD TTM Op. Margin: 0.0%
ABSI TTM Op. Margin: -9108.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABSI. Trailing 12-month operating profitability (IPOD 0.0% vs ABSI -9108.3%) and valuation multiples (IPOD N/M vs ABSI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IPOD | ABSI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $210.0M | $1.5B | Larger Scale | ABSI |
| Trailing P/E Ratio Valuation | 39.9x | N/M | Lower Multiple | IPOD |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -19.6% | Higher Growth | IPOD |
| Operating Margin (TTM) Profitability | 0.0% | -9108.3% | Higher Margin | IPOD |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -58.6% | Higher ROE | IPOD |
| 52-Week Range Position Momentum | 100% ($10โ$10) | 51% ($2โ$13) | Stronger Trend | IPOD |
| Beta / 30D Volatility Risk Regime | 0.00ฮฒ ยท 2% Vol | 3.34ฮฒ ยท 128% Vol | Lower Realized Risk | IPOD |
| Unified Institutional Score Composite Signal | 58.0 / 100 (HOLD) | 41.3 / 100 (SELL) | Higher Composite | IPOD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IPOD vs ABSI Buy Guide
IPOD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABSI
BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IPOD nor ABSI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.